UBS AM’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,164
| Closed | -$1.34K | – | 2668 |
|
|
2025
Q1 | $1.34K | Buy |
+1,164
| New | +$1.34K | ﹤0.01% | 2635 |
|
|
2023
Q4 | – | Sell |
-11,145
| Closed | -$93.1K | – | 2567 |
|
|
2023
Q3 | $93.1K | Sell |
11,145
-473,882
| -98% | -$3.96M | ﹤0.01% | 2568 |
|
|
2023
Q2 | $6.66M | Hold |
485,027
| – | – | ﹤0.01% | 1113 |
|
|
2023
Q1 | $6.66M | Buy |
485,027
+328
| +0.1% | +$4.51K | ﹤0.01% | 1113 |
|
|
2022
Q4 | $8.24M | Sell |
484,699
-39,612
| -8% | -$674K | ﹤0.01% | 1011 |
|
|
2022
Q3 | $11.9M | Sell |
524,311
-12,098
| -2% | -$275K | 0.01% | 900 |
|
|
2022
Q2 | $9.67M | Sell |
536,409
-24,302
| -4% | -$438K | 0.01% | 970 |
|
|
2022
Q1 | $15M | Buy |
560,711
+200,032
| +55% | +$5.35M | 0.01% | 930 |
|
|
2021
Q4 | $10.6M | Buy |
360,679
+44,712
| +14% | +$1.31M | ﹤0.01% | 1110 |
|
|
2021
Q3 | $20.8M | Sell |
315,967
-19,612
| -6% | -$1.29M | 0.01% | 852 |
|
|
2021
Q2 | $27.9M | Buy |
335,579
+83,647
| +33% | +$6.96M | 0.01% | 800 |
|
|
2021
Q1 | $19.3M | Sell |
251,932
-47,018
| -16% | -$3.61M | 0.01% | 871 |
|
|
2020
Q4 | $26.4M | Buy |
298,950
+193,331
| +183% | +$17.1M | 0.01% | 772 |
|
|
2020
Q3 | $7.8M | Buy |
105,619
+26,287
| +33% | +$1.94M | ﹤0.01% | 1011 |
|
|
2020
Q2 | $5.79M | Buy |
+79,332
| New | +$5.79M | ﹤0.01% | 1061 |
|